| scholarly article | Q13442814 |
| P2093 | author name string | D L Rothman | |
| G I Shulman | |||
| G W Cline | |||
| K F Petersen | |||
| D Laurent | |||
| P2860 | cites work | Effects of glucose on glycogen synthetase, phosphorylase, and glycogen deposition in the perfused rat liver | Q33690501 |
| Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. | Q34983779 | ||
| Pathways of glycogen repletion | Q35531440 | ||
| Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load | Q35583720 | ||
| 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus | Q35824562 | ||
| The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog | Q35905321 | ||
| Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange | Q35996659 | ||
| Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon | Q37031053 | ||
| The Control of Glycogen Metabolism in the Liver | Q37116559 | ||
| Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. | Q37351019 | ||
| Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study | Q37372215 | ||
| The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans | Q39759818 | ||
| Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo | Q39764273 | ||
| Regulation of hepatic glucose metabolism in humans | Q39764293 | ||
| Control of hepatic glucose output by glucagon and insulin in the intact dog | Q39792878 | ||
| The control of glycogen synthesis in the liver | Q39893016 | ||
| Control of hepatic glycogen metabolism in the rhesus monkey: effect of glucose, insulin, and glucagon administration | Q39940337 | ||
| Hormonal and ionic control of the glycogenolytic cascade in rat liver | Q40063096 | ||
| Control of hepatic glycogenolysis | Q40119596 | ||
| Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. | Q40529785 | ||
| Insulin regulation of hepatic glycogen synthase and phosphorylase | Q41352719 | ||
| Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man | Q41452468 | ||
| The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations | Q42093073 | ||
| Insulin activates 6-phosphofructo-2-kinase and pyruvate kinase in the liver. Indirect evidence for an action via a phosphatase | Q44573553 | ||
| Underestimation of glucose turnover corrected with high-performance liquid chromatography purification of [6-3H]glucose. | Q44668493 | ||
| Liver glycogen turnover in fed and fasted humans. | Q51595366 | ||
| Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. | Q51614550 | ||
| Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. | Q52558244 | ||
| Effects of anaerobiosis, glucose, insulin and glucagon on glycogen metabolism in isolated parenchymal rat liver cells. | Q54417288 | ||
| Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose. | Q54601890 | ||
| Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates | Q68161753 | ||
| The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose | Q68679515 | ||
| Interaction of insulin and glucose in the control of hepatic glucose balance | Q68854239 | ||
| Menstrual cyclicity has a profound effect on glucose homeostasis | Q69520307 | ||
| Inhibition of hepatic glucose production by insulin in vivo in rats: contribution of glycolysis | Q70136510 | ||
| Dose-response characteristics for effects of insulin on production and utilization of glucose in man | Q70157794 | ||
| Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats | Q70182631 | ||
| Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period | Q71441652 | ||
| Control of rat liver glycogen synthetase and phosphorylase activities by glucose | Q71617875 | ||
| A microfluorometric method for the determination of free fatty acids in plasma | Q71689514 | ||
| Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms | Q72623456 | ||
| EFFECTS OF INSULIN ON LIVER GLYCOGEN SYNTHESIS AND BREAKDOWN IN THE DOG | Q77231668 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| glycogen catabolic process | Q680603 | ||
| glycobiology | Q899224 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 1203-1209 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans | |
| P478 | volume | 101 |
| Q43071713 | A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition |
| Q37050347 | Activation of basal gluconeogenesis by coactivator p300 maintains hepatic glycogen storage |
| Q38349186 | Akt2 is required for hepatic lipid accumulation in models of insulin resistance. |
| Q44775968 | Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes |
| Q53959740 | Cellular mechanism of insulin resistance in skeletal muscle. |
| Q46870494 | Changes in hepatic glycogen cycling during a glucose load in healthy humans |
| Q28590643 | Deficiency of a glycogen synthase-associated protein, Epm2aip1, causes decreased glycogen synthesis and hepatic insulin resistance |
| Q47875169 | Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis |
| Q44843310 | Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans. |
| Q34370865 | Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose. |
| Q34370965 | Disordered lipid metabolism and the pathogenesis of insulin resistance |
| Q44058300 | Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans |
| Q37728252 | Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin |
| Q54453100 | Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. |
| Q43852611 | Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs |
| Q44673749 | Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog. |
| Q37429165 | Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. |
| Q51558698 | Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans. |
| Q51353301 | Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. |
| Q44135925 | Elucidation of the role of fructose 2,6-bisphosphate in the regulation of glucose fluxes in mice using in vivo (13)C NMR measurements of hepatic carbohydrate metabolism |
| Q89726847 | Epinephrine responsiveness is reduced in livers from trained mice |
| Q44715661 | Evaluation of hepatic and whole body glycogen metabolism in humans during repeated administrations of small loads of 13C glucose |
| Q44030214 | FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis |
| Q92539006 | Fructose co-ingestion to increase carbohydrate availability in athletes |
| Q33718965 | GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production. |
| Q51244251 | Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans. |
| Q49928562 | Glucose effectiveness is a critical pathogenic factor leading to the emergence of glucose intolerance and type 2 diabetes mellitus: an ignored hypothesis |
| Q48882834 | Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency. |
| Q44361959 | Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles |
| Q49329608 | Growth Hormone Control of Hepatic Lipid Metabolism |
| Q36351511 | Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice |
| Q35214635 | Hepatic glucose metabolism in humans--its role in health and disease |
| Q34722593 | Hepatic glucose production: therapeutic target in type 2 diabetes? |
| Q34361034 | Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis |
| Q89170092 | Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome |
| Q38009669 | Hepatic steatosis in type 1 diabetes |
| Q37896899 | Hormonal regulation of hepatic glucose production in health and disease |
| Q37386093 | How to measure hepatic insulin resistance? |
| Q97652933 | Hyperglycemia-stimulating diet induces liver steatosis in sheep |
| Q51467371 | Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study. |
| Q42447333 | Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects |
| Q45238638 | Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog. |
| Q36477267 | Increased hepatic glucose production in fetal sheep with intrauterine growth restriction is not suppressed by insulin |
| Q44222459 | Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition |
| Q34543004 | Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance |
| Q50226931 | Insulin regulation of gluconeogenesis |
| Q42022525 | Insulin:Carbohydrate Ratio--Part of the Story |
| Q45211549 | Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT. |
| Q33731949 | Limitations in the use of [U-13C6]glucose to estimate gluconeogenesis |
| Q92798647 | Lipometabolism and Glycometabolism in Liver Diseases |
| Q38902789 | Liver glycogen metabolism during and after prolonged endurance-type exercise |
| Q103803522 | Lkb1 suppresses amino acid-driven gluconeogenesis in the liver |
| Q26776006 | Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review |
| Q22241286 | Mechanism by which metformin reduces glucose production in type 2 diabetes |
| Q90685522 | Mechanisms of Insulin Action and Insulin Resistance |
| Q90437850 | Metabolic control analysis of hepatic glycogen synthesis in vivo |
| Q34334102 | Methods for measuring glycogen cycling |
| Q91795538 | Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants |
| Q64068197 | Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet |
| Q33869713 | Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo |
| Q24320564 | Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0 |
| Q47779219 | Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases |
| Q42870991 | PP2A inhibition results in hepatic insulin resistance despite Akt2 activation |
| Q92504940 | Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease |
| Q34237562 | Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy |
| Q38289039 | Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin |
| Q36560594 | Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs |
| Q35043435 | Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. |
| Q44599780 | Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog |
| Q50787306 | Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults. |
| Q30596447 | Quantifying the contribution of gluconeogenesis to glucose production in fasted human subjects using stable isotopes |
| Q40845558 | Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells |
| Q35214633 | Regulation of hepatic and peripheral glucose disposal |
| Q34796024 | Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance |
| Q39450184 | Regulation of hepatic glucose metabolism in health and disease |
| Q37264170 | Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans |
| Q34370839 | Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes |
| Q51559959 | Regulatory role of glucose-6 phosphatase in the repletion of liver glycogen during refeeding in fasted rats. |
| Q58197185 | Spatial Compartmentalization in the Regulation of Glucose Metabolism by Insulin |
| Q64933050 | Sulforaphane Prevents Hepatic Insulin Resistance by Blocking Serine Palmitoyltransferase 3-Mediated Ceramide Biosynthesis. |
| Q55365059 | The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action. |
| Q33836122 | The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects |
| Q38419053 | The forgotten role of glucose effectiveness in the regulation of glucose tolerance |
| Q24644267 | The impact of obesity, sex, and diet on hepatic glucose production in cats |
| Q51476013 | The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat. |
| Q36430696 | The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux |
| Q38247935 | The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents. |
| Q35811523 | The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes |
| Q37766160 | The use of magnetic resonance methods in translational cardiovascular research |
| Q37488846 | Three cases of glycogenic hepatopathy mimicking acute and relapsing hepatitis in type I diabetes mellitus |
| Q37286814 | Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats |
| Q24629603 | Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance |
| Q35214630 | Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions |
Search more.